Calibrate is on a mission to change the way the world treats weight. As the leading clinician-guided and value-based outcomes model in obesity treatment, Calibrate combines medication with transformative behavior change to improve overall metabolic health, driving cost-effective, long-term weight loss results while reducing the total cost of care for employers and payers. Recognized by esteemed organizations, including the World Economic Forum's Technology Pioneers, Fast Company's World Changing Ideas, TIME's Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Calibrate is backed by leading healthcare investors, including Madryn Asset Management, and Redesign Health.